XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Shareholders' Equity - USD ($)
Total
Common Stock
Deferred Equity Compensation
Retained Earnings
Beginning Balance (in shares) at Dec. 31, 2019   3,294,672    
Beginning Balance at Dec. 31, 2019 $ 192,855,681 $ 95,853,477 $ (20,331,890) $ 117,334,094
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (in shares)   22,099    
Issuance of restricted stock grants   $ 2,548,440 (2,548,440)  
Amortization of restricted stock grants 5,227,574   5,227,574  
Issuance of stock grants (in shares)   23,640    
Common stock issued as incentive compensation 3,396,359 $ 3,396,359    
Issuance of common stock related to 401k plan match (in shares)   20,976    
Issuance of common stock related to 401(k) plan match 2,511,746 $ 2,511,746    
Shares withheld related to employee tax withholding (shares)   (19,189)    
Shares withheld related to employee tax withholding obligations (1,947,456) $ (1,947,456)    
Forfeiture of restricted stock grants (in shares)   (15,625)    
Forfeiture of restricted stock grants   $ (2,904,638) 2,904,638  
Repurchases of common stock (in shares)   (157,750)    
Repurchases of common stock (18,646,982) $ (18,646,982)    
Cash dividend paid of $6.00 in 2016, $7.00 in 2017, and $8.00 in 2018 per share respectively (37,976,714)     (37,976,714)
Net income attributable to parent 38,660,545     38,660,545
Ending Balance (in shares) at Dec. 31, 2020   3,168,823    
Ending Balance at Dec. 31, 2020 184,080,753 $ 80,810,946 (14,748,118) 118,017,925
Beginning balances attributable to redeemable noncontrolling interests at Dec. 31, 2019 14,178,824      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net (loss) income attributable to redeemable noncontrolling interests (495,407)      
Net subscriptions of consolidated funds (4,311,084)      
Ending balances attributable to redeemable noncontrolling interests at Dec. 31, 2020 9,372,333      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (in shares)   69,879    
Issuance of restricted stock grants   $ 11,105,508 (11,105,508)  
Amortization of restricted stock grants 7,182,299   7,182,299  
Issuance of stock grants (in shares)   3,681    
Common stock issued as incentive compensation 529,806 $ 529,806    
Issuance of common stock related to 401k plan match (in shares)   506    
Issuance of common stock related to 401(k) plan match 87,667 $ 87,667    
Issuance of common stock related to employee stock purchase plan (shares)   4,278    
Issuance of common stock related to employee stock purchase plan 748,472 $ 748,472    
Shares withheld related to employee tax withholding (shares)   (10,057)    
Shares withheld related to employee tax withholding obligations (1,625,413) $ (1,625,413)    
Forfeiture of restricted stock grants (in shares)   (19,847)    
Forfeiture of restricted stock grants 0 $ (3,402,622) 3,402,622  
Repurchases of common stock (in shares)   (45,727)    
Repurchases of common stock (7,820,315) $ (7,820,315)    
Cash dividend paid of $6.00 in 2016, $7.00 in 2017, and $8.00 in 2018 per share respectively (72,960,976)     (72,960,976)
Net income attributable to parent $ 74,200,609     74,200,609
Ending Balance (in shares) at Dec. 31, 2021 3,171,536 3,171,536    
Ending Balance at Dec. 31, 2021 $ 184,422,902 $ 80,434,049 (15,268,705) 119,257,558
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net (loss) income attributable to redeemable noncontrolling interests 1,388,930      
Net subscriptions of consolidated funds 10,298,891      
Net deconsolidations of Company sponsored investments (3,303,818)      
Ending balances attributable to redeemable noncontrolling interests at Dec. 31, 2021 17,756,336      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (in shares)   76,143    
Issuance of restricted stock grants   $ 13,436,439 (13,436,439)  
Amortization of restricted stock grants 10,530,486   10,530,486  
Issuance of stock grants (in shares)   2,743    
Common stock issued as incentive compensation 487,870 $ 487,870    
Issuance of common stock related to 401k plan match (in shares)   211    
Issuance of common stock related to 401(k) plan match 37,313 $ 37,313    
Issuance of common stock related to employee stock purchase plan (shares)   3,392    
Issuance of common stock related to employee stock purchase plan 619,159 $ 619,159    
Shares withheld related to employee tax withholding (shares)   (19,302)    
Shares withheld related to employee tax withholding obligations (3,436,678) $ (3,436,678)    
Forfeiture of restricted stock grants (in shares)   (7,257)    
Forfeiture of restricted stock grants   $ (1,163,514) 1,163,514  
Repurchases of common stock (in shares)   (217,009)    
Repurchases of common stock (38,726,007) $ (38,726,007)    
Cash dividend paid of $6.00 in 2016, $7.00 in 2017, and $8.00 in 2018 per share respectively (30,696,907)     (30,696,907)
Net income attributable to parent $ 40,434,107     40,434,107
Ending Balance (in shares) at Dec. 31, 2022 3,010,457 3,010,457    
Ending Balance at Dec. 31, 2022 $ 163,672,245 $ 51,688,631 $ (17,011,144) $ 128,994,758
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net (loss) income attributable to redeemable noncontrolling interests (3,563,345)      
Net subscriptions of consolidated funds 9,461,710      
Net deconsolidations of Company sponsored investments (9,528,503)      
Ending balances attributable to redeemable noncontrolling interests at Dec. 31, 2022 $ 14,126,198